Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The airway epithelial secretory machinery is a coordinated system of proteins and organelles responsible for the regulated exocytosis of mucins and other protective factors from specialized cells, such as goblet cells and submucosal gland cells. This machinery relies on a core set of proteins including the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex—specifically Syntaxin-3, SNAP-23, and VAMP-8—alongside regulatory proteins like Munc13-2, Munc18, and Synaptotagmin-2 (Davis & Dickey, 2008, Annual Review of Physiology). These components facilitate the docking, priming, and fusion of large mucin-containing granules with the apical plasma membrane in response to agonists like ATP or inflammatory mediators (Fahy & Dickey, 2010, NEJM). In chronic airway diseases such as asthma and COPD, the machinery is often upregulated or hyper-responsive, leading to pathological mucus hypersecretion and airway obstruction. Therapeutic targeting of this system, such as through the inhibition of the MARCKS protein which tethers granules to the cytoskeleton, aims to reduce excessive mucus release without completely abolishing the baseline secretion necessary for lung defense (Kim et al., 2015, American Journal of Respiratory Cell and Molecular Biology).
Inhibition of vesicle docking and fusion, cleavage of SNARE proteins (e.g., SNAP-23), inhibition of MARCKS-mediated granule translocation, and disruption of Munc13-2-dependent priming of secretory granules.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway epithelial secretory machinery.